Infusion Devices: Technologies and Global Markets

Infusion Devices: Technologies and Global Markets published by BCC Research in February, 2010. This report consists of 194 pages and the price starts from US $ 4850.

Introduction

Abstract

• Focus on end-user markets, including hospitals, research facilities, freestanding clinics, and doctors' offices that use the devices to administer therapeutics such as analgesics, antimicrobials, blood products, chemotherapy, and nutrients.
• Provide data on the global market for the devices in 2008, and forecast the market from 2009 through 2014.
• Discuss well-established technologies, such as electronic syringe infusion devices, injection pens, needleless jet injectors, as well as emerging technologies, such as transdermal drug delivery for illnesses such as cardiovascular disease.
• Examine improvements in quality, effectiveness, and safety.

STUDY GOALS AND OBJECTIVES

BCC' s goal in conducting this study was to determine the current status of the global market for infusion pumps and assess its growth potential over a 5-year period from 2009 to 2014. Of particular interest were changes to the regulatory environment and delivery infrastructure due to healthcare reform in the U.S. and other countries, and the rapid changes in product offerings following a series of high-profile product recalls over the past 2 years.

In addition, BCC was interested in describing the transition to “smart pump” technology and giving an overview of the complex systems that complement and compete with infusion pumps as mode of treatment.

The key objective was to present a comprehensive analysis of the current market for infusion pumps and its future growth prospects in providing safe and effective delivery of medications, nutrients, and analgesics.

REASONS FOR DOING THE STUDY

Almost every aspect of the infusion pump sector is undergoing dramatic change at this time. In response to numerous product recalls, manufacturers have introduced new smart pump technology to reduce Adverse Drug Events (ADEs) and other serious problems associated with previous administrative methods.

Competition from other drug delivery systems, chiefly transdermal and inhaled medicines, may put boundaries on growth for infusion pumps. Demand is growing for continuous administration of medicines and analgesics due to demographic changes in the world' s population and the increasing incidence of diabetes. Ancillary devices such as meters and monitors are becoming a significant force in the market, and design changes have produced new pumps that are smaller, less obtrusive, and have a sense of style, rendering them much more acceptable as ambulatory infusion pumps.

BCC is interested in charting the interplay between these various factors and how they will interact with other changes occurring in the broader landscape of healthcare delivery.

SCOPE OF REPORT

This report covers infusion pumps used for continuous or intermittent administration of medications (including antibiotics), nutrients, and analgesics. BCC analyzes current conditions in the global market and examines the current market condition and variable factors to forecast the future growth of the market. Medical, scientific, technological, social, and economic issues associated with this market are examined. An educated estimate and forecast of growth from 2009 to 2014 are presented by examining the current market and variable factors of each category of diagnostic or therapeutic product.

INFORMATION SOURCES

BCC surveyed approximately 45 companies to obtain data for this study. Included were manufacturers of infusion pumps, transdermal drug delivery systems, inhaled medications, glucose monitoring devices, medical device distributors, pharmaceutical manufacturers, and manufacturers of needleless injectors. BCC also spoke with government agency regulators, industry personnel, and medical science personnel. In addition, data was compiled from current financial, legal, trade information, and government sources.

ANALYST CREDENTIALS

Thomas Fuller has been a market research analyst for 15 years and has published numerous reports on technology products and market issues. Fuller has broad experience in covering regulatory and consumer issues, and currently advises companies on business strategy in the healthcare sector.

Table of Contents

Infusion Devices: Technologies and Global Markets

Chapter- 1: INTRODUCTION -- Complimentary

• STUDY GOALS AND OBJECTIVES
• REASONS FOR DOING THE STUDY
• SCOPE OF REPORT
• INTENDED AUDIENCE
• INFORMATION SOURCES
• ANALYST CREDENTIALS
• RELATED BCC REPORTS
• BCC ONLINE SERVICES
• DISCLAIMER

Chapter-2: SUMMARY

• SUMMARY
• SUMMARY (CONTINUED)
• SUMMARY TABLE GLOBAL INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
• SUMMARY FIGURE GLOBAL INFUSION PUMP SPENDING BY GEOGRAPHIC REGION, 2008-2014 ($ MILLIONS)

Chapter-3: OVERVIEW

• INDUSTRY DEFINITION
• INFUSION PUMPS
• Importance of Infusion Pumps
• General
• Drug-delivery Systems
• Drug-...(Continued)
• Product and Technology Life Cycle
• HISTORY OF INFUSION
• HISTORY OF INFUSION (CONTINUED)
• INDUSTRY DEVELOPMENT
• FORECAST
• CURRENT ACTIVITY
• CURRENT STATE OF INFUSION DEVICES AND THERAPIES
• DEMAND AND COST
• DEMOGRAPHIC FACTORS
• Demographic Factors (Continued)
• 2009 IN REVIEW
• INDUSTRY DEVELOPMENTS
• CAREFUSION/ALARIS
• SMITHS MEDICAL
• BAXTER, COLLEAGUE, SIGMA, AND SPECTRUM
• KIMBERLY CLARK AND I-FLOW
• MEDINGO
• MOOG ROLL-UP STRATEGY
• YEAR(S) OF THE RECALL
• DEVELOPMENTS OUTSIDE THE INDUSTRY
• PORTABLE DIALYSIS MACHINE
• ISLET CELL INJECTION
• U.S. HEALTHCARE REFORM
• MEDICAL DEVICE MANUFACTURERS TAX
• HOME INFUSION THERAPY
• MEDICAL DEVICES REGISTRY
• SUNSHINE PROVISION
• COMPARATIVE EFFECTIVENESS RESEARCH

Chapter-4: MAJOR COMPANIES AND MARKET SHARE

• MAJOR COMPANIES AND MARKET SHARE
  • TABLE 1 GLOBAL MEDICAL INFUSION PUMP EXPENDITURES BY TYPE OF PUMP, THROUGH 2014 ($ MILLIONS)
  • FIGURE 1 GLOBAL MEDICAL INFUSION PUMP EXPENDITURES, 2008-2014 ($ MILLIONS)
• MAJOR MARKETS
  • FIGURE 2 HEALTHCARE EXPENDITURES AS PERCENTAGE OF GDP (%)
• U.S.
• JAPAN
• CANADA
• AUSTRALIA

Chapter-5: MARKETS BY PRODUCT

• MARKETS BY PRODUCT
• ELASTOMERIC AND MECHANICAL INFUSION PUMPS
• ELASTOMERIC PUMPS
• PERISTALTIC PUMPS
• CASSETTE PUMPS
  • TABLE 2 GLOBAL MANUFACTURERS OF ELASTOMERIC AND MECHANICAL INFUSION PUMPS MARKET SHARE, 2008 (%)
  • FIGURE 3 GLOBAL MANUFACTURERS OF ELASTOMERIC AND MECHANICAL INFUSION PUMPS GLOBAL MARKET SHARE, 2008 (%)
  • TABLE 3 GLOBAL MEDICAL ELASTOMERIC AND MECHANICAL INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 4 U.S. MEDICAL ELASTOMERIC AND MECHANICAL INFUSION PUMP MARKET BY SECTOR, THROUGH 2014 ($ MILLIONS)
• SYRINGE PUMPS
  • TABLE 5 GLOBAL SYRINGE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 4 GLOBAL SYRINGE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 6 GLOBAL MEDICAL SYRINGE INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 7 U.S. MEDICAL SYRINGE INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
• ELECTRONIC SYRINGE INFUSION PUMPS
  • TABLE 8 GLOBAL ELECTRONIC SYRINGE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 5 GLOBAL ELECTRONIC SYRINGE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 9 GLOBAL ELECTRONIC SYRINGE INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 10 GLOBAL ELECTRONIC SYRINGE PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 11 U.S. ELECTRONIC SYRINGE INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
• IIPS
• IIPs (Continued)
  • TABLE 12 GLOBAL IMPLANTABLE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 6 GLOBAL IMPLANTABLE INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 13 U.S. IMPLANTABLE INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
  • TABLE 14 GLOBAL MEDICAL IMPLANTABLE INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)

Chapter-6: TYPES OF APPLICATIONS

• VOLUMETRIC INFUSION PUMPS
  • TABLE 15 GLOBAL VOLUMETRIC INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 7 GLOBAL VOLUMETRIC INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 16 GLOBAL VOLUMETRIC INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 17 U.S. VOLUMETRIC INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
• SMART PUMPS
  • TABLE 18 GLOBAL SMART PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 8 GLOBAL SMART INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 19 GLOBAL SMART INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 20 U.S. SMART INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
• SMART PUMPS (CONTINUED)
• AMBULATORY INFUSION PUMPS
  • TABLE 21 GLOBAL AMBULATORY INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 9 GLOBAL AMBULATORY INFUSION PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 22 GLOBAL AMBULATORY INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 23 U.S. AMBULATORY INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)
• INSULIN PUMPS
• INSULIN PUMPS (CONTINUED)
  • TABLE 24 GLOBAL INSULIN PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • FIGURE 10 GLOBAL INSULIN PUMP MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 25 GLOBAL INSULIN INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
  • TABLE 26 U.S. INSULIN INFUSION PUMP EXPENDITURES BY MARKET SECTOR, THROUGH 2014 ($ MILLIONS)

Chapter-7: CONDITIONS

• CONDITIONS PAIN MANAGEMENT
• PAIN MANAGEMENT (CONTINUED)
• MEDICATION
• DIABETES
• ENTERAL NUTRITION
• PN
• ANTIBIOTICS

Chapter-8: COMPETING AND COMPLEMENTARY TECHNOLOGIES

• NEEDLELESS INJECTORS
  • TABLE 27 GLOBAL NEEDLELESS INJECTOR MANUFACTURERS' MARKET SHARE BASED ON DOLLAR SALES, 2008 (%)
  • TABLE 27 (CONTINUED)
• NEEDLELESS INJECTORS (CONTINUED)
• INJECTION PENS
• MINIBAGS
• GLUCOSE MONITORING
• SELF-MONITORING OF BLOOD GLUCOSE
• CGMS
• TRADITIONAL INSULIN DELIVERY
• DISRUPTIVE TECHNOLOGY CHALLENGES
• TRANSDERMAL DRUG DELIVERY
• TRANSDERMAL DRUG DELIVERY (CONTINUED)
• TRANSDERMAL DRUG DELIVERY (CONTINUED)
• TRANSDERMAL DRUG DELIVERY (CONTINUED)
• TRANSDERMAL DRUG DELIVERY (CONTINUED)
• TRANSDERMAL PATCH PUMPS
• INHALED MEDICATIONS AND DEVICES
• Inhaled Medications ... (Continued)
  • TABLE 28 PROGRESS TOWARD NEEDLEFREE VACCINE DELIVERY
  • TABLE 28 (CONTINUED)
  • TABLE 28 (CONTINUED)
  • TABLE 28 (CONTINUED)
  • TABLE 28 (CONTINUED)
  • TABLE 28 (CONTINUED)
• NANOTECHNOLOGY
• NANOTECHNOLOGY (CONTINUED
• BIOTECHNOLOGY
• BIOTECHNOLOGY (CONTINUED)

Chapter-9: GOVERNMENT REGULATIONS

• U.S. FDA
• FDA PRE-MARKET REVIEW
• FDA PRE-MARKET REVIEW PROCESS UNDER SCRUTINY
• FDA REPORTING AND VIGILANCE
• FDA RECALLS
  • TABLE 29 KEY FDA PRODUCT RECALLS: INFUSION PUMPS, 2007 - 2009
  • TABLE 29 (CONTINUED)
  • TABLE 29 (CONTINUED)
  • TABLE 29 (CONTINUED)
  • TABLE 29 (CONTINUED)
  • TABLE 29 (CONTINUED)
• FDA AND STATE AND LOCAL GOVERNMENTS
• MEDICARE AND MEDICAID
• MEDICARE
• MEDICARE NATIONAL GUIDELINES: INFUSION DEVICE COVERAGE
  • TABLE 30 NATIONAL MEDICARE COVERAGE DETERMINATIONS PERTAINING TO INFUSION DEVICES
  • TABLE 30 (CONTINUED)
• MEDICARE AND HOME INFUSION
• Medicare Part A Covers Drugs and Equipment for Hospital and Hospice Stays
• MEDICAID
• Medicaid (Continued)

Chapter-10: CLINICAL GUIDELINES BY PROFESSIONAL GROUPS

• THE JOINT COMMISSION
• ECRI INSTITUTE
• THE INSTITUTE FOR SAFE MEDICATION PRACTICES (ISMP)
• THE ASSOCIATION FOR THE ADVANCEMENT OF MEDICAL INSTRUMENTATION (AAMI)
• THE ISO

Chapter-11: PATIENT SAFETY

• INTRODUCTION
• INFUSION PUMPS
• INSULIN PENS
• NEEDLELESS JET INJECTORS
• IIPS
• ELASTOMERIC INFUSION PUMPS

Chapter-12: INDUSTRY STRUCTURE

• FORCES DRIVING THE INDUSTRY
• CURRENT PERFORMANCE
• INDUSTRY CONTEXT
• MANUFACTURERS
• DISTRIBUTORS
• GOVERNMENTS AND REGULATORY BODIES
• INSURANCE COMPANIES
• HOSPITALS
  • TABLE 31 U.S. HOSPITAL EXPENDITURES ON INFUSION PUMPS BY TECHNOLOGY TYPE, THROUGH 2014 ($ MILLIONS)
• GROUP PURCHASING ORGANIZATIONS
• THE HOME INFUSION SECTOR
  • TABLE 32 U.S. HOME INFUSION PROVIDERS' , INCLUDING PHARMACIES, EXPENDITURES ON INFUSION PUMPS BY TECHNOLOGY TYPE, THROUGH 2014 ($ MILLIONS)
• FULL-SERVICE PROVIDERS
• NURSING CARE PROVIDERS
• DRUG PROVIDERS
• PROVISION OF INFUSION THERAPY SERVICES
• GOVERNMENT
• INFUSION THERAPY DELIVERY MODELS
• INFUSION THERAPY IN AN ALTERNATE SITE
  • TABLE 33 U.S. DOCTORS' OFFICE EXPENDITURES ON INFUSION PUMPS BY TECHNOLOGY TYPE, THROUGH 2014 ($ MILLIONS)
  • TABLE 34 U.S. ALTERNATE SITE EXPENDITURES ON INFUSION PUMPS BY TECHNOLOGY TYPE, THROUGH 2014 ($ MILLIONS)

Chapter-13: INTERNATIONAL ASPECTS

• TABLE 35 GLOBAL INFUSION PUMP EXPENDITURES BY GEOGRAPHIC REGION, THROUGH 2014 ($ MILLIONS)
• TABLE 36 GEOGRAPHIC DISTRIBUTION OF MAJOR MANUFACTURERS' SALES (%)
• INTERNATIONAL REGULATIONS
  • TABLE 37 SIGNIFICANT INTERNATIONAL REGULATORY ACTION
• AUSTRALIA
• CANADA
• EUROPEAN UNION
• JAPAN
• REST OF ASIA
• Rest of Asia (Continued)

Chapter-14: TRENDS IN PRICE AND PRICE/PERFORMANCE

• GENERAL INFUSION PUMP
• PV/LCC ANALYSIS ASSUMPTIONS
• INSULIN PUMPS
  • TABLE 38 COMPARING COSTS OF INSULIN ADMINISTRATION METHODS ($)
• OTHER FACTORS INFLUENCING DEMAND
• COST
• CLINICAL EFFECTIVENESS
• ERRORS
• SMART INFRASTRUCTURE
• TRAINING
• Training Time
• DEMOGRAPHICS
• General
  • TABLE 39 DEMOGRAPHIC PROJECTIONS THROUGH 2050 (POPULATION IN MILLIONS)
  • TABLE 40 AGING OF WORLD POPULATION, 2000 AND 2014
• Diabetes
  • TABLE 41 GLOBAL INCIDENCE OF DIABETES, 2000 AND 2030
  • TABLE 42 LEADING COUNTRIES, DIABETES, 2000 AND 2030 (MILLIONS)
• Cancer
• U.S.
• MARKET SATURATION
• Market Saturation /Continued)

Chapter-15: TECHNOLOGY, INCLUDING PATENT EVALUATION

• TECHNOLOGY, INCLUDING PATENT EVALUATION
• TECHNOLOGY, INCLUDING PATENT ... (CONTINUED)
  • TABLE 43 U.S. MEDICATORS AND RECEPTORS PATENTS, GENERAL ACTIVITY IN SELECTED COMPANIES, 2004 - 2008
  • TABLE 43 (CONTINUED)
  • TABLE 44 GLOBAL PATENT ACTIVITY IN INFUSION PUMP TECHNOLOGIES, 2005 - 2009
  • TABLE 44 (CONTINUED)
• PATENT ACTIVITY 2009: ELASTOMERIC INFUSION PUMPS
  • TABLE 45 GLOBAL PATENT ACTIVITY 2009: ELASTOMERIC INFUSION PUMPS
• PATENT ACTIVITY 2009: INJECTION PENS
  • TABLE 46 GLOBAL PATENT ACTIVITY 2009: INJECTION PENS
• PATENT ACTIVITY 2009: NEEDLELESS INJECTOR JETS
  • TABLE 47 GLOBAL PATENT ACTIVITY 2009: NEEDLELESS INJECTOR JETS
• PATENT ACTIVITY 2009: MECHANICAL INFUSION PUMPS
  • TABLE 48 GLOBAL PATENT ACTIVITY 2009: MECHANICAL INFUSION PUMPS
  • TABLE 48 (CONTINUED)
• PATENT ACTIVITY 2009: SYRINGE PUMPS

Chapter-16: COMPANY PROFILES

• INFUSION PUMPS
• ALARIS MEDICAL SYSTEMS, INC.
• BAXA
• B. BRAUN MELSUNGEN AG
• B. Braun Medical, Inc.
• BAXTER INT' L, INC.
• CAREFUSION
• COVIDIEN, PLC/KENDALL
• Kendall
• KENDALL CO.
• FRESENIUS KABI AG
• HOSPIRA, INC.
• KIMBERLY-CLARK CORP./I-FLOW
• I-FLOW CORP.
• LMA INT' L
• LMA North America, Inc.
• MOOG, INC.
• SIGMA INT' L
• SMITHS MEDICAL
• STRYKER CORP.
• TERUMO CORP.
• Terumo Medical Corp.
• ZHUKAI FORNIA
• Ashlar Holdings, LLC
• INSULIN PUMPS
• ANIMAS CORP.
• DEBIOTECH
• INSULET CORP.
• JOHNSON & JOHNSON CO.
• Animas
• Codman & Shurtleff, Inc.
• MEDINGO MEDICAL SOLUTIONS
• Medingo Medical Solutions U.S.
• MEDTRONIC, INC.
• MEDTRONIC DIABETES
• NIPRO CORP.
• Nipro Diabetes Systems
• ROCHE DIAGNOSTICS CORP.
• SOOIL DEVELOPMENT
• SOOIL Development U.S.
• NEEDLELESS INJECTORS
• ANTARES PHARMA, INC.
• BIOJECT MEDICAL TECHNOLOGIES, INC.
• CROSSJECT
• INJEX-EQUIDYNE SYSTEMS
• NATIONAL MEDICAL PRODUCTS, INC.
• PFIZERM, INC.
• ZOGENIX
• MINIBAGS
• INHALED/TRANSDERMAL DRUG DELIVERY SYSTEMS
• 3M DRUG DELIVERY SYSTEMS
• ALKERMES, INC.
• ARADIGM CORP.
• MANNKIND CORP.
• VECTURA
• INJECTION PENS
• NOVO NORDISK A/S
• Novo Nordisk U.S.
• Novo Nordisk U.S. (Continued)
• OWEN MUMFORD, LTD.
• YPSOMED
• Ypsomed (Continued)

Chapter-17: APPENDIX

• APPENDIX
  • TABLE 49 GLOBAL PATENTS AND PATENT APPLICATIONS BY COMPANY, 2009
  • TABLE 49 (CONTINUED)
  • TABLE 49 (CONTINUED)
  • TABLE 49 (CONTINUED)
  • TABLE 49 (CONTINUED)

Press Release

Infusion pump sector currently undergoing dramatic changes

Related Reports